2022
DOI: 10.1016/j.amjcard.2022.04.028
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes in Patients With Heart Failure Using Cocaine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…In a retrospective cohort that compared 738 cocaine users with heart failure with reduced ejection fraction (HFrEF) with matched non-cocaine users, cocaine consumption was linked to elevated risks of all-cause mortality, heart failure readmission, and overall readmission. Both nonselective and selective βblockers could serve as safe treatment options for patients with heart failure and concomitant cocaine use [12].…”
Section: Discussionmentioning
confidence: 99%
“…In a retrospective cohort that compared 738 cocaine users with heart failure with reduced ejection fraction (HFrEF) with matched non-cocaine users, cocaine consumption was linked to elevated risks of all-cause mortality, heart failure readmission, and overall readmission. Both nonselective and selective βblockers could serve as safe treatment options for patients with heart failure and concomitant cocaine use [12].…”
Section: Discussionmentioning
confidence: 99%
“…10 Among 133 patients with available medication prescription data, researchers found no significant differences in 30-day readmission or 1-year mortality, regardless of whether the patients received a β-blocker prescription. 10…”
Section: Why There Is No Reason To Stop β-Blockers In Patients Who Us...mentioning
confidence: 97%
“…Less robust evidence supports the safety of continuation of β‐blockers in patients with active cocaine use and comorbid HFrEF. One retrospective cohort study sought to compare readmissions and all‐cause mortality among patients with HFrEF who use cocaine 10 . Among 133 patients with available medication prescription data, researchers found no significant differences in 30‐day readmission or 1‐year mortality, regardless of whether the patients received a β‐blocker prescription 10 …”
Section: Clinical Scenariomentioning
confidence: 99%